Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1869756314;56315;56316 chr2:178599812;178599811;178599810chr2:179464539;179464538;179464537
N2AB1705651391;51392;51393 chr2:178599812;178599811;178599810chr2:179464539;179464538;179464537
N2A1612948610;48611;48612 chr2:178599812;178599811;178599810chr2:179464539;179464538;179464537
N2B963229119;29120;29121 chr2:178599812;178599811;178599810chr2:179464539;179464538;179464537
Novex-1975729494;29495;29496 chr2:178599812;178599811;178599810chr2:179464539;179464538;179464537
Novex-2982429695;29696;29697 chr2:178599812;178599811;178599810chr2:179464539;179464538;179464537
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAA
  • RefSeq wild type template codon: CTT
  • Domain: Ig-116
  • Domain position: 10
  • Structural Position: 18
  • Q(SASA): 0.7314
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/D rs767433299 -0.15 0.996 N 0.541 0.219 0.288727942641 gnomAD-2.1.1 4.17E-06 None None None None N None 0 0 None 0 0 None 0 None 0 9.11E-06 0
E/D rs767433299 -0.15 0.996 N 0.541 0.219 0.288727942641 gnomAD-4.0.0 1.61808E-06 None None None None N None 0 0 None 0 0 None 0 0 2.89149E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.1854 likely_benign 0.1755 benign -0.436 Destabilizing 0.619 D 0.447 neutral N 0.469277424 None None N
E/C 0.8881 likely_pathogenic 0.8972 pathogenic -0.098 Destabilizing 1.0 D 0.731 prob.delet. None None None None N
E/D 0.283 likely_benign 0.3248 benign -0.38 Destabilizing 0.996 D 0.541 neutral N 0.513606992 None None N
E/F 0.8561 likely_pathogenic 0.8663 pathogenic -0.289 Destabilizing 1.0 D 0.717 prob.delet. None None None None N
E/G 0.313 likely_benign 0.3239 benign -0.631 Destabilizing 0.984 D 0.65 neutral D 0.52769101 None None N
E/H 0.6508 likely_pathogenic 0.6803 pathogenic -0.028 Destabilizing 1.0 D 0.653 neutral None None None None N
E/I 0.4355 ambiguous 0.4309 ambiguous 0.045 Stabilizing 0.999 D 0.714 prob.delet. None None None None N
E/K 0.175 likely_benign 0.2064 benign 0.308 Stabilizing 0.992 D 0.642 neutral N 0.474779245 None None N
E/L 0.442 ambiguous 0.4408 ambiguous 0.045 Stabilizing 0.998 D 0.661 neutral None None None None N
E/M 0.525 ambiguous 0.511 ambiguous 0.135 Stabilizing 1.0 D 0.69 prob.neutral None None None None N
E/N 0.4582 ambiguous 0.4979 ambiguous -0.067 Destabilizing 1.0 D 0.685 prob.neutral None None None None N
E/P 0.431 ambiguous 0.4839 ambiguous -0.095 Destabilizing 0.999 D 0.67 neutral None None None None N
E/Q 0.1701 likely_benign 0.1783 benign -0.031 Destabilizing 1.0 D 0.603 neutral N 0.490306058 None None N
E/R 0.296 likely_benign 0.339 benign 0.523 Stabilizing 0.999 D 0.683 prob.neutral None None None None N
E/S 0.3438 ambiguous 0.3514 ambiguous -0.214 Destabilizing 0.988 D 0.642 neutral None None None None N
E/T 0.3005 likely_benign 0.2936 benign -0.052 Destabilizing 0.998 D 0.63 neutral None None None None N
E/V 0.2556 likely_benign 0.244 benign -0.095 Destabilizing 0.998 D 0.612 neutral N 0.475070033 None None N
E/W 0.9439 likely_pathogenic 0.9537 pathogenic -0.121 Destabilizing 1.0 D 0.741 deleterious None None None None N
E/Y 0.7785 likely_pathogenic 0.8118 pathogenic -0.044 Destabilizing 1.0 D 0.7 prob.neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.